血管補片市場規模、佔有率及成長分析（按材料、應用和地區）—產業預測，2025 年至 2032 年

血管貼片市場規模預計在 2023 年達到 4.1867 億美元，2024 年達到 4.5258 億美元，到 2032 年達到 8.4393 億美元，在預測期內（2025-2032 年）的複合年成長率為 8.10%。

慢性腎臟病(CKD) 逐漸影響腎臟功能，越來越被認為是糖尿病、高血壓和心血管疾病的重要危險因子。隨著 CKD 的進展，身體難以有效調節體液、電解質和廢物，這可能導致危險的積聚。美國國家糖尿病、消化和腎臟疾病研究所最近的統計數據顯示，美國有超過 3700 萬成年人患有 CKD，凸顯了對 CKD 認知和管理策略的迫切需求。這種日益成長的盛行率為醫療保健提供者和政策制定者提供了巨大的機會，使他們能夠專注於預防、早期發現和創新治療方案，以改善患者的治療效果並減輕併發症的負擔。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 重大投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究

血管補片市場規模（按材料和複合年成長率） (2025-2032)

• 市場概覽
• 生物血管補片
• 合成血管補片

血管補片市場規模（依應用及複合年成長率） （2025 年至 2032 年）

• 市場概覽
• 頸動脈切除術
• 腹部主動脈血管瘤開放式修補術
• 血管搭橋手術
• 先天性心臟疾病
• 其他用途

血管補片市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 門診手術中心

血管貼片市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Baxter International Inc.（USA）
• Terumo Corporation（Japan）
• Edwards Lifesciences Corporation（USA）
• Getinge AB（Sweden）
• B. Braun SE（Germany）
• LeMaitre Vascular, Inc.（USA）
• WL Gore & Associates, Inc.（USA）
• Artivion, Inc.（formerly CryoLife, Inc.）（USA）
• Aziyo Biologics, Inc.（USA）
• Vascudyne, Inc.（USA）
• Collagen Solutions Plc（UK）
• FOC Medical SA（Switzerland）
• Obex Medical Ltd.（New Zealand）
• Vascumed（Pty）Ltd.（South Africa）
• Celox Medical（UK）
• Biom'up（France）
• Hemovent GmbH（Germany）
• Kuros Biosciences AG（Switzerland）
• Medtronic plc（Ireland）
• Abbott Laboratories（USA）

結論和建議

Vascular Patches Market size was valued at USD 418.67 Million in 2023 and is poised to grow from USD 452.58 Million in 2024 to USD 843.93 Million by 2032, growing at a CAGR of 8.10% during the forecast period (2025-2032).

Chronic kidney disease (CKD) is increasingly recognized as a significant risk factor for diabetes, hypertension, and cardiovascular diseases due to its gradual impact on kidney function. With the progression of CKD, the body struggles to regulate fluids, electrolytes, and waste effectively, which can result in dangerous buildups. Recent statistics from the National Institute of Diabetes and Digestive and Kidney Diseases reveal that more than 37 million adults in the United States are affected by CKD, highlighting the urgent need for awareness and management strategies. This growing prevalence indicates a considerable opportunity for healthcare providers and policymakers to focus on prevention, early detection, and innovative treatment solutions in order to improve patient outcomes and reduce the burden of associated comorbidities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vascular Patches market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vascular Patches Market Segments Analysis

The global Vascular Patches Market is segmented into three segments i.e. by Material, Application and Region. Based on material, the market is segmented into Biologic Vascular Patches, Synthetic Vascular Patches. Based on Application, the market is segmented into Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, Other Applications. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver of the Vascular Patches Market

The swift growth of the global elderly population is a major driver of the increasing prevalence of various health issues, including cardiovascular diseases, high cholesterol levels, hypertension, strokes, cancer, and aneurysms. Aging is a critical factor impacting cardiovascular health, and the rise in the elderly demographic significantly influences market growth in the vascular patches sector. As more individuals age, the demand for medical solutions addressing these age-related conditions surges, thereby stimulating advancements and investments in vascular patch technologies. This demographic trend underscores the urgent need for effective treatment options, further propelling the market forward.

Restraints in the Vascular Patches Market

The anticipated challenge to the growth of the Vascular Patches market during the forecast period is primarily linked to an increase in product recalls. For instance, Baxter International, a leading healthcare provider located in Illinois, recently initiated a recall of its Vascu-Guard peripheral vascular patch. Such recalls highlight prevailing quality and safety issues associated with certain medical products, which are expected to hinder the overall market's expansion. This particular incident underscores the significant effects that such events can have on market dynamics, potentially undermining consumer confidence and adversely affecting industry performance in the upcoming years.

Market Trends of the Vascular Patches Market

The vascular patches market is experiencing significant growth, driven by the rising adoption of minimally invasive procedures like MIDCAB (Minimally Invasive Direct Coronary Artery Bypass). This trend is fueled by a growing preference for safe, low-mortality interventions, alongside the compatibility of MIDCAB with cardiopulmonary bypass and aortic cross-clamping. As innovations in surgical techniques, including the use of coronary artery stent grafts, continue to evolve, they are expected to further stimulate demand for vascular grafts. Consequently, the market is poised for expansion, as healthcare providers increasingly prioritize advanced solutions that enhance patient outcomes and recovery times.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Vascular Patches Market Size by Material & CAGR (2025-2032)

• Market Overview
• Biologic Vascular Patches
• Synthetic Vascular Patches

Global Vascular Patches Market Size by Application & CAGR (2025-2032)

• Market Overview
• Carotid Endarterectomy
• Open Repair of Abdominal Aortic Aneurysm
• Vascular Bypass Surgery
• Congenital Heart Disease
• Other Applications

Global Vascular Patches Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers

Global Vascular Patches Market Size & CAGR (2025-2032)

• North America (Material, Application, End User)
  • US
  • Canada
• Europe (Material, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeMaitre Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion, Inc. (formerly CryoLife, Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aziyo Biologics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascudyne, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collagen Solutions Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FOC Medical S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Obex Medical Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascumed (Pty) Ltd. (South Africa)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celox Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biom'up (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemovent GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations